Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin

Seminars in Cancer Biology

Volumn 15, Issue 4, 2005, Pages 277-289

  Lechner, Matthias ^a   Lirk, Philipp ^a   Rieder, Josef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cancerogenesis; Inducible nitric oxide synthase; Inhibition; Tumor progression

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TUMOR PROMOTER;

ANGIOGENESIS; APOPTOSIS; BIOLOGY; BLOOD PRESSURE REGULATION; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; CYTOTOXICITY; DIABETES MELLITUS; ENZYME ACTIVITY; HOST RESISTANCE; INFECTION; INFLAMMATION; LIVER CIRRHOSIS; MACROPHAGE; METASTASIS; MICROENVIRONMENT; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR; TUMOR PROMOTION; WOUND HEALING;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 23044511645     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.04.004     Document Type: Review

References (189)

1. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem J 298 Pt 2 1994 249 258
2. J. Garthwaite, S.L. Charles, and R. Chess-Williams Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain Nature 336 6197 1988 385 388
3. M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf, and J.S. Wishnok Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate Biochemistry 27 24 1988 8706 8711
4. R.G. Knowles Nitric oxide synthases Biochem Soc Trans 24 3 1996 875 878
5. D.J. Stuehr, N.S. Kwon, C.F. Nathan, O.W. Griffith, P.L. Feldman, and J. Wiseman N omega-hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine J Biol Chem 266 10 1991 6259 6263
6. G. Michal Biochemical pathways 1999 John Wiley & Sons New York
7. H.H. Schmidt, H. Hofmann, U. Schindler, Z.S. Shutenko, D.D. Cunningham, and M. Feelisch No. NO from NO synthase Proc Natl Acad Sci USA 93 25 1996 14492 14497
8. A.J. Hobbs, J.M. Fukuto, and L.J. Ignarro Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase Proc Natl Acad Sci USA 91 23 1994 10992 10996
9. S.I. Liochev, and I. Fridovich Copper, zinc superoxide dismutase as a univalent NO(-) oxidoreductase and as a dichlorofluorescin peroxidase J Biol Chem 276 38 2001 35253 35257
10. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci USA 87 4 1990 1620 1624
11. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem J 357 Pt 3 2001 593 615
12. C.S. Park, G. Krishna, M.S. Ahn, J.H. Kang, W.G. Chung, and D.J. Kim Differential and constitutive expression of neuronal, inducible, and endothelial nitric oxide synthase mRNAs and proteins in pathologically normal human tissues Nitric Oxide 4 5 2000 459 471
13. N.T. Eissa, J.W. Yuan, C.M. Haggerty, E.K. Choo, C.D. Palmer, and J. Moss Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization Proc Natl Acad Sci USA 95 13 1998 7625 7630
14. U. Siddhanta, C. Wu, H.M. Abu-Soud, J. Zhang, D.K. Ghosh, and D.J. Stuehr Heme iron reduction and catalysis by a nitric oxide synthase heterodimer containing one reductase and two oxygenase domains J Biol Chem 271 13 1996 7309 7312
15. N.T. Eissa, C.M. Haggerty, C.D. Palmer, W. Patton, and J. Moss Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase Am J Respir Cell Mol Biol 24 5 2001 616 620
16. W. Xu, I.G. Charles, S. Moncada, P. Gorman, D. Sheer, and L. Liu Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively Genomics 21 2 1994 419 422
17. B.S. Taylor, and D.A. Geller Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene Shock 13 6 2000 413 424
18. H.J. Cho, Q.W. Xie, J. Calaycay, R.A. Mumford, K.M. Swiderek, and T.D. Lee Calmodulin is a subunit of nitric oxide synthase from macrophages J Exp Med 176 2 1992 599 604
19. D.J. Stuehr, and O.W. Griffith Mammalian nitric oxide synthases Adv Enzymol Relat Areas Mol Biol 65 1992 287 346
20. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu Rev Immunol 15 1997 323 350
21. I.G. Charles, R.M. Palmer, M.S. Hickery, M.T. Bayliss, A.P. Chubb, and V.S. Hall Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte Proc Natl Acad Sci USA 90 23 1993 11419 11423
22. R.D. Curran, T.R. Billiar, D.J. Stuehr, J.B. Ochoa, B.G. Harbrecht, and S.G. Flint Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis Ann Surg 212 4 1990 462 469 [discussion 470-1]
23. D.A. Geller, C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, and S.C. Wang Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes Proc Natl Acad Sci USA 90 8 1993 3491 3495
24. S. Sethi, and M. Dikshit Modulation of polymorphonuclear leukocytes function by nitric oxide Thromb Res 100 3 2000 223 247
25. K. Asano, C.B. Chee, B. Gaston, C.M. Lilly, C. Gerard, and J.M. Drazen Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells Proc Natl Acad Sci USA 91 21 1994 10089 10093
26. A. Perner, L. Andresen, M. Normark, and J. Rask-Madsen Constitutive expression of inducible nitric oxide synthase in the normal human colonic epithelium Scand J Gastroenterol 37 2002 944 948
27. M.J. Hickey, D.N. Granger, and P. Kubes Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice Acta Physiol Scand 173 1 2001 119 126
28. L. Kobzik, D.S. Bredt, C.J. Lowenstein, J. Drazen, B. Gaston, and D. Sugarbaker Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization Am J Respir Cell Mol Biol 9 4 1993 371 377
29. M. de Vera, R. Shapiro, A. Nussler, J. Mudgett, R. Simmons, and S. Morris Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter Proc Natl Acad Sci USA 93 1996 1054 1059
30. J.B. Mannick, K. Asano, K. Izumi, E. Kieff, and J.S. Stamler Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation Cell 79 7 1994 1137 1146
31. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB J 6 12 1992 3051 3064
32. C.R. Ferreiro, A.C. Chagas, M.H. Carvalho, A.P. Dantas, M.B. Jatene, and L.C. Bento De Souza Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: a novel pathophysiological adaptive mechanism Circulation 103 18 2001 2272 2276
33. H.J. Yoon, C.D. Jun, J.M. Kim, G.N. Rim, H.M. Kim, and H.T. Chung Phorbol ester synergistically increases interferon-gamma-induced nitric oxide synthesis in murine microglial cells Neuroimmunomodulation 1 6 1994 377 382
34. E.D. Chan, J. Chan, and N.W. Schluger What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge Am J Respir Cell Mol Biol 25 5 2001 606 612
35. Y.T. Xuan, Y. Guo, H. Han, Y. Zhu, and R. Bolli An essential role of the JAK-STAT pathway in ischemic preconditioning Proc Natl Acad Sci USA 98 16 2001 9050 9055
36. H. Kleinert, T. Wallerath, G. Fritz, I. Ihrig-Biedert, F. Rodriguez-Pascual, and D.A. Geller Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways Br J Pharmacol 125 1 1998 193 201
37. Y.M. Janssen-Heininger, I. Macara, and B.T. Mossman Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants Am J Respir Cell Mol Biol 20 5 1999 942 952
38. D.A. Geller, M.E. de Vera, D.A. Russell, R.A. Shapiro, A.K. Nussler, and R.L. Simmons A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis J Immunol 155 10 1995 4890 4898
39. A.K. Kiemer, and A.M. Vollmar Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide J Biol Chem 273 22 1998 13444 13451
40. D. Kunz, G. Walker, W. Eberhardt, and J. Pfeilschifter Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation Proc Natl Acad Sci USA 93 1 1996 255 259
41. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 5 Pt 1 1996 C1424 C1437
42. R.E. Huie, and S. Padmaja The reaction of no with superoxide Free Radic Res Commun 18 4 1993 195 199
43. J.S. Beckman, H. Ischiropoulos, L. Zhu, M. van der Woerd, C. Smith, and J. Chen Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite Arch Biochem Biophys 298 2 1992 438 445
44. L.D. Buttery, D.R. Springall, A.H. Chester, T.J. Evans, E.N. Standfield, and D.V. Parums Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite Lab Invest 75 1 1996 77 85
45. V.M. Darley-Usmar, N. Hogg, V.J. O'Leary, M.T. Wilson, and S. Moncada The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein Free Radic Res Commun 17 1 1992 9 20
46. N.W. Kooy, S.J. Lewis, J.A. Royall, Y.Z. Ye, D.R. Kelly, and J.S. Beckman Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite Crit Care Med 25 5 1997 812 819
47. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, and N.J. Sucher A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 6438 1993 626 632
48. D.A. Wink, J.A. Cook, R. Pacelli, J. Liebmann, M.C. Krishna, and J.B. Mitchell Nitric oxide (NO) protects against cellular damage by reactive oxygen species Toxicol Lett 82-83 1995 221 226
49. J.S. Beckman The double-edged role of nitric oxide in brain function and superoxide-mediated injury J Dev Physiol 15 1 1991 53 59
50. M.G. Salgo, K. Stone, G.L. Squadrito, J.R. Battista, and W.A. Pryor Peroxynitrite causes DNA nicks in plasmid pBR322 Biochem Biophys Res Commun 210 3 1995 1025 1030
51. D.A. Wink, K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, and T.M. Dunams DNA deaminating ability and genotoxicity of nitric oxide and its progenitors Science 254 5034 1991 1001 1003
52. T. Nguyen, D. Brunson, C.L. Crespi, B.W. Penman, J.S. Wishnok, and S.R. Tannenbaum DNA damage and mutation in human cells exposed to nitric oxide in vitro Proc Natl Acad Sci USA 89 7 1992 3030 3034
53. K. Merchant, H. Chen, T.C. Gonzalez, L.K. Keefer, and B.R. Shaw Deamination of single-stranded DNA cytosine residues in aerobic nitric oxide solution at micromolar total NO exposures Chem Res Toxicol 9 5 1996 891 896
54. K.D. Kroncke, K. Fehsel, and V. Kolb-Bachofen Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1 2 1997 107 120
55. J.S. Stamler, O. Jaraki, J. Osborne, D.I. Simon, J. Keaney, and J. Vita Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin Proc Natl Acad Sci USA 89 16 1992 7674 7677
56. J.S. Stamler Redox signaling: nitrosylation and related target interactions of nitric oxide Cell 78 6 1994 931 936
57. H. Ohshima, and H. Bartsch Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis Mutat Res 305 2 1994 253 264
58. R.H. Liu, and J.H. Hotchkiss Potential genotoxicity of chronically elevated nitric oxide: a review Mutat Res 339 2 1995 73 89
59. F. Laval, D.A. Wink, and J. Laval A discussion of mechanisms of NO genotoxicity: implication of inhibition of DNA repair proteins Rev Physiol Biochem Pharmacol 131 1997 175 191
60. 2 reaction Chem Res Toxicol 7 4 1994 519 525
61. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, and J.B. Mitchell The multifaceted roles of nitric oxide in cancer Carcinogenesis 19 5 1998 711 721
62. D.A. Wink, and J. Laval The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo Carcinogenesis 15 10 1994 2125 2129
63. D.A. Wink, and J.B. Mitchell Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic Biol Med 25 4/5 1998 434 456
64. K. Forrester, S. Ambs, S.E. Lupold, R.B. Kapust, E.A. Spillare, and W.C. Weinberg Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53 Proc Natl Acad Sci USA 93 6 1996 2442 2447
65. U.K. Messmer, M. Ankarcrona, P. Nicotera, and B. Brune p53 expression in nitric oxide-induced apoptosis FEBS Lett 355 1 1994 23 26
66. K. Sandau, J. Pfeilschifter, and B. Brune The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells J Immunol 158 10 1997 4938 4946
67. P.A. Brennan, and S. Moncada From pollutant gas to biological messenger: the diverse actions of nitric oxide in cancer Ann R Coll Surg Engl 84 2 2002 75 78
68. S. Ambs, W.G. Merriam, M.O. Ogunfusika, W.P. Bennett, N. Ishibe, and S.P. Hussain p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells Nat Med 4 12 1998 1371 1376
69. J.E. Goodman, L.J. Hofseth, S.P. Hussain, and C.C. Harris Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease Environ Mol Mutagen 44 1 2004 3 9
70. C.V. Rao Nitric oxide signaling in colon cancer chemoprevention Mutat Res 555 1/2 2004 107 119
71. P. Lirk, G. Hoffmann, and J. Rieder Inducible nitric oxide synthase - time for reappraisal Curr Drug Targets Inflamm Allergy 1 1 2002 89 108
72. M. Vakkala, K. Kahlos, E. Lakari, P. Paakko, V. Kinnula, and Y. Soini Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas Clin Cancer Res 6 6 2000 2408 2416
73. A.J. Marrogi, W.D. Travis, J.A. Welsh, M.A. Khan, H. Rahim, and H. Tazelaar Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma Clin Cancer Res 6 12 2000 4739 4744
74. S.H. Aaltoma, P.K. Lipponen, and V.M. Kosma Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer Anticancer Res 21 4B 2001 3101 3106
75. S.H. Aaltomaa, P.K. Lipponen, J. Viitanen, J.P. Kankkunen, M.Y. Ala-Opas, and V.M. Kosma The prognostic value of inducible nitric oxide synthase in local prostate cancer BJU Int 86 3 2000 234 239
76. P. Uotila, E. Valve, P. Martikainen, M. Nevalainen, M. Nurmi, and P. Harkonen Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer Urol Res 29 1 2001 23 28
77. H.S. Swana, S.D. Smith, P.L. Perrotta, N. Saito, M.A. Wheeler, and R.M. Weiss Inducible nitric oxide synthase with transitional cell carcinoma of the bladder J Urol 161 2 1999 630 634
78. H. Hayashi, M. Kuwahara, N. Fujisaki, M. Furihata, Y. Ohtsuki, and S. Kagawa Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia Oncol Rep 8 6 2001 1275 1279
79. M. Kojima, T. Morisaki, Y. Tsukahara, A. Uchiyama, Y. Matsunari, and R. Mibu Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue J Surg Oncol 70 4 1999 222 229
80. D. Massi, A. Franchi, I. Sardi, L. Magnelli, M. Paglierani, and L. Borgognoni Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions J Pathol 194 2 2001 194 200
81. J.A. Crowell, V.E. Steele, C.C. Sigman, and J.R. Fay Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2 8 2003 815 823
82. R. Radi, J.S. Beckman, K.M. Bush, and B.A. Freeman Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide J Biol Chem 266 7 1991 4244 4250
83. J.K. Selkirk Chemical carcinogenesis: a brief overview of the mechanism of action of polycyclic hydrocarbons, aromatic amines, nitrosamines, and aflatoxins Carcinog Compr Surv 5 1980 1 31
84. T. Nguyen, D. Brunson, C.L. Crespi, B.W. Penman, J.S. Wishnok, and S.R. Tannenbaum DNA damage and mutation in human cells exposed to nitric oxide in vitro Proc Natl Acad Sci USA 89 7 1992 3030 3034
85. 6-methylguanine-DNA-methyltransferase Carcinogenesis 15 3 1994 443 447
86. O. Sidorkina, M.G. Espey, K.M. Miranda, D.A. Wink, and J. Laval Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species Free Radic Biol Med 35 11 2003 1431 1438
87. S. Burney, J.L. Caulfield, J.C. Niles, J.S. Wishnok, and S.R. Tannenbaum The chemistry of DNA damage from nitric oxide and peroxynitrite Mutat Res 424 1/2 1999 37 49
88. M.G. Salgo, E. Bermudez, G.L. Squadrito, and W.A. Pryor Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes [corrected] Arch Biochem Biophys 322 2 1995 500 505
89. S. Moochhala, and A. Rajnakova Role of nitric oxide in cancer biology Free Radic Res 31 6 1999 671 679
90. C. Cadwell, and G.P. Zambetti The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth Gene 277 1/2 2001 15 30
91. C. Prives, and P.A. Hall The p53 pathway J Pathol 187 1 1999 112 126
92. T. Miyashita, S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, and D.A. Libermann Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 6 1994 1799 1805
93. K.H. Moberg, W.A. Tyndall, and D.J. Hall Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line J Cell Biochem 49 2 1992 208 215
94. X.Y. Yin, L. Grove, N.S. Datta, M.W. Long, and E.V. Prochownik C-myc overexpression and p53 loss cooperate to promote genomic instability Oncogene 18 5 1999 1177 1184
95. S. Tsuji, M. Tsujii, W.H. Sun, E.S. Gunawan, H. Murata, and S. Kawano Helicobacter pylori and gastric carcinogenesis J Clin Gastroenterol 25 Suppl. 1 1997 S186 S197
96. L.L. Thomsen, J.M. Scott, P. Topley, R.G. Knowles, A.J. Keerie, and A.J. Frend Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 W, a novel inhibitor Cancer Res 57 15 1997 3300 3304
97. S. Ambs, S.P. Hussain, and C.C. Harris Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression FASEB J. 11 6 1997 443 448
98. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1 1990 4 6
99. K. Chin, Y. Kurashima, T. Ogura, H. Tajiri, S. Yoshida, and H. Esumi Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells Oncogene 15 4 1997 437 442
100. H.T. Yang, Z. Yan, J.A. Abraham, and R.L. Terjung VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production Am J Physiol Heart Circ Physiol 280 3 2001 H1097 H1104
101. T. Murohara, T. Asahara, M. Silver, C. Bauters, H. Masuda, and C. Kalka Nitric oxide synthase modulates angiogenesis in response to tissue ischemia J Clin Invest 101 11 1998 2567 2578
102. S. Frank, B. Stallmeyer, H. Kampfer, C. Schaffner, and J. Pfeilschifter Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells Biochem J 338 Pt 2 1999 367 374
103. A. Papapetropoulos, G. Garcia-Cardena, J.A. Madri, and W.C. Sessa Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells J Clin Invest 100 12 1997 3131 3139
104. S.P. Andrade, I.R. Hart, and P.J. Piper Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature Br J Pharmacol 107 4 1992 1092 1095
105. S. Vamvakas, and H.H. Schmidt Just say NO to cancer? J Natl Cancer Inst 89 6 1997 406 407
106. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, I. Sardi, and N. Lasagna Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin Cancer Res 10 8 2004 2694 2704
107. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, and S.A. Baylis Roles of nitric oxide in tumor growth Proc Natl Acad Sci USA 92 10 1995 4392 4396
108. H. Maeda, Y. Noguchi, K. Sato, and T. Akaike Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor Jpn J Cancer Res 85 4 1994 331 334
109. G.M. Tozer, V.E. Prise, and D.J. Chaplin Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with l-arginine Cancer Res 57 5 1997 948 955
110. P.J. Andrew, H. Harant, and I.J. Lindley Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level Biochem Biophys Res Commun 214 3 1995 949 956
111. Q. Xiong, Q. Shi, X. Le, B. Wang, and K. Xie Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma J Interferon Cytokine Res 21 7 2001 529 537
112. K. Xie Interleukin-8 and human cancer biology Cytokine Growth Factor Rev 12 4 2001 375 391
113. N.E. Hubbard, and K.L. Erickson Role of 5′-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function Cell Immunol 160 1 1995 115 122
114. J.M. Ray, and W.G. Stetler-Stevenson The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis Eur Respir J 7 11 1994 2062 2072
115. F. Tronc, Z. Mallat, S. Lehoux, M. Wassef, B. Esposito, and A. Tedgui Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO Arterioscler Thromb Vasc Biol 20 12 2000 E120 E126
116. T. Okamoto, T. Akaike, T. Nagano, S. Miyajima, M. Suga, and M. Ando Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide Arch Biochem Biophys 342 2 1997 261 274
117. K. Sasaki, T. Hattori, T. Fujisawa, K. Takahashi, H. Inoue, and M. Takigawa Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes J Biochem (Tokyo) 123 3 1998 431 439
118. G.R. Upchurch Jr., J.W. Ford, S.J. Weiss, B.S. Knipp, D.A. Peterson, and R.W. Thompson Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro J Vasc Surg 34 1 2001 76 83
119. W. Eberhardt, T. Beeg, K.F. Beck, S. Walpen, S. Gauer, and J. Pfeilschifter Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells Kidney Int 57 1 2000 59 69
120. P. Macchiarini, G. Fontanini, M.J. Hardin, F. Squartini, and C.A. Angeletti Relation of neovascularisation to metastasis of non-small-cell lung cancer Lancet 340 8812 1992 145 146
121. C.S. Cobbs, J.E. Brenman, K.D. Aldape, D.S. Bredt, and M.A. Israel Expression of nitric oxide synthase in human central nervous system tumors Cancer Res 55 4 1995 727 730
122. T. Klotz, W. Bloch, C. Volberg, U. Engelmann, and K. Addicks Selective expression of inducible nitric oxide synthase in human prostate carcinoma Cancer 82 10 1998 1897 1903
123. L.L. Thomsen, D.W. Miles, L. Happerfield, L.G. Bobrow, R.G. Knowles, and S. Moncada Nitric oxide synthase activity in human breast cancer Br J Cancer 72 1 1995 41 44
124. N.Z. Wu, B. Klitzman, R. Dodge, and M.W. Dewhirst Diminished leukocyte-endothelium interaction in tumor microvessels Cancer Res 52 15 1992 4265 4268
125. P. Lejeune, P. Lagadec, N. Onier, D. Pinard, H. Ohshima, and J.F. Jeannin Nitric oxide involvement in tumor-induced immunosuppression J Immunol 152 10 1994 5077 5083
126. M. Spiecker, H. Darius, K. Kaboth, F. Hubner, and J.K. Liao Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants J Leukoc Biol 63 6 1998 732 739
127. B.V. Khan, D.G. Harrison, M.T. Olbrych, R.W. Alexander, and R.M. Medford Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells Proc Natl Acad Sci USA 93 17 1996 9114 9119
128. K. Ivanova, I.C. Le Poole, R. Gerzer, W. Westerhof, and P.K. Das Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components J Pathol 183 4 1997 469 476
129. J. Yao, H.O. Schoecklmann, F. Prols, S. Gauer, and R.B. Sterzel Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components Kidney Int 53 3 1998 598 608
130. S.R. Frenkel, R.M. Clancy, J.L. Ricci, P.E. Di Cesare, J.J. Rediske, and S.B. Abramson Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly Arthritis Rheum 39 11 1996 1905 1912
131. W.G. Stetler-Stevenson, S. Aznavoorian, and L.A. Liotta Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9 1993 541 573
132. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 23 1989 6449 6465
133. Y. Boucher, L.T. Baxter, and R.K. Jain Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy Cancer Res 50 15 1990 4478 4484
134. D. Glaves Intravascular death of disseminated cancer cells mediated by superoxide anion Invasion Metastasis 6 2 1986 101 111
135. K. Mortensen, I.J. Christensen, H.J. Nielsen, U. Hansen, and L.I. Larsson High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased disease-free survival in colorectal cancer Cancer Lett 216 1 2004 109 114
136. L. Kong, G.D. Dunn, L.K. Keefer, and R.J. Korthuis Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules Clin Exp Metastasis 14 4 1996 335 343
137. B. Wang, D. Wei, V.E. Crum, E.L. Richardson, H.H. Xiong, and Y. Luo A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis Oncogene 22 12 2003 1771 1782
138. B. Wang, Q. Xiong, Q. Shi, X. Le, and K. Xie Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase Oncogene 20 47 2001 6930 6937
139. E. Pipili-Synetos, A. Papageorgiou, E. Sakkoula, G. Sotiropoulou, T. Fotsis, and G. Karakiulakis Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate Br J Pharmacol 116 2 1995 1829 1834
140. I.J. Fidler Review: biologic heterogeneity of cancer metastases Breast Cancer Res Treat 9 1 1987 17 26
141. M.W. Radomski, D.C. Jenkins, L. Holmes, and S. Moncada Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets Cancer Res 51 22 1991 6073 6078
142. D.J. Stuehr, and C.F. Nathan Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells J Exp Med 169 5 1989 1543 1555
143. L.M. Li, R.G. Kilbourn, J. Adams, and I.J. Fidler Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells Cancer Res 51 10 1991 2531 2535
144. D. Fukumura, Y. Yonei, I. Kurose, H. Saito, T. Ohishi, and H. Higuchi Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo Hepatology 24 1 1996 141 149
145. H. Jiang, C.A. Stewart, D.J. Fast, and R.W. Leu Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target J Immunol 149 6 1992 2137 2146
146. L. Xiao, P.H. Eneroth, and G.A. Qureshi Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity Scand J Immunol 42 5 1995 505 511
147. J.E. Albina, S. Cui, R.B. Mateo, and J.S. Reichner Nitric oxide-mediated apoptosis in murine peritoneal macrophages J Immunol 150 11 1993 5080 5085
148. S. Gansauge, A.K. Nussler, H.G. Beger, and F. Gansauge Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 Cell Growth Differ 9 8 1998 611 617
149. K. Mortensen, J. Skouv, D.M. Hougaard, and L.I. Larsson Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53 J Biol Chem 274 53 1999 37679 37684
150. J.Y. Kwak, M.K. Han, K.S. Choi, I.H. Park, S.Y. Park, and M.H. Sohn Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells Cell Immunol 203 2 2000 84 94
151. A.M. Genaro, S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels J Clin Invest 95 4 1995 1884 1890
152. E. Tzeng, T.R. Billiar, D.L. Williams, J. Li, A. Lizonova, and I. Kovesdi Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis Surgery 124 2 1998 278 283
153. W. Xu, L. Liu, G.C. Smith, and G. Charles Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents Nat Cell Biol 2 6 2000 339 345
154. S. Vaganay-Juery, C. Muller, E. Marangoni, B. Abdulkarim, E. Deutsch, and P. Lambin Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation Br J Cancer 83 4 2000 514 518
155. G.C. Smith, and S.P. Jackson The DNA-dependent protein kinase Genes Dev 13 8 1999 916 934
156. T. Yamamoto, N. Terada, Y. Nishizawa, H. Tanaka, H. Akedo, and A. Seiyama Effects of NG-nitro-l-arginine and/or l-arginine on experimental pulmonary metastasis in mice Cancer Lett 87 1 1994 115 120
157. G. Cantuaria, A. Magalhaes, R. Angioli, L. Mendez, R. Mirhashemi, and J. Wang Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma Cancer 88 2 2000 381 388
158. W.G. Yu, N. Yamamoto, H. Takenaka, J. Mu, X.G. Tai, and J.P. Zou Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12 Int Immunol 8 6 1996 855 865
159. C. Binder, M. Schulz, W. Hiddemann, and M. Oellerich Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells Lab Invest 79 12 1999 1703 1712
160. C.J. Bruns, H. Shinohara, M.T. Harbison, D.W. Davis, G. Nelkin, and J.J. Killion Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages Cancer Res 60 1 2000 2 7
161. J. Rieder, C. Marth, G. Totzke, M. Smolny, M. Seibel, and G. Hoffmann Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines Anticancer Res 20 5A 2000 3251 3258
162. J. Rieder, R. Jahnke, M. Schloesser, M. Seibel, M. Czechowski, and C. Marth Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines Gynecol Oncol 82 1 2001 172 176
163. H.J. Garban, and B. Bonavida Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis Gynecol Oncol 73 2 1999 257 264
164. H.J. Garban, and B. Bonavida Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells J Immunol 167 1 2001 75 81
165. A. Yamazaki, and H.C. Birnboim Potentiation of retinoic acid-induced U-937 differentiation into respiratory burst-competent cells by nitric oxide donors Leukoc Res 19 5 1995 325 335
166. L. Sandirasegarane, R. Charles, N. Bourbon, and M. Kester NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest Am J Physiol Cell Physiol 279 1 2000 C225 C235
167. Z. Dong, A.H. Staroselsky, X. Qi, K. Xie, and I.J. Fidler Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells Cancer Res 54 3 1994 789 793
168. Q. Shi, Q. Xiong, B. Wang, X. Le, N.A. Khan, and K. Xie Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis Cancer Res 60 10 2000 2579 2583
169. K. Xie, and I.J. Fidler Therapy of cancer metastasis by activation of the inducible nitric oxide synthase Cancer Metastasis Rev 17 1 1998 55 75
170. G.J. Gasic, T.B. Gasic, N. Galanti, T. Johnson, and S. Murphy Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease Int J Cancer 11 3 1973 704 718
171. C. Philippe, B. Philippe, B. Fouqueray, J. Perez, M. Lebret, and L. Baud Protection from tumor necrosis factor-mediated cytolysis by platelets Am J Pathol 143 6 1993 1713 1723
172. A.B. Malik Pulmonary microembolism Physiol Rev 63 3 1983 1114 1207
173. G. Sawicki, E. Salas, J. Murat, H. Miszta-Lane, and M.W. Radomski Release of gelatinase A during platelet activation mediates aggregation Nature 386 6625 1997 616 619
174. P. Jurasz, M.W. Stewart, A. Radomski, F. Khadour, M. Duszyk, and M.W. Radomski Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin Br J Pharmacol 134 5 2001 1104 1112
175. M.W. Radomski, R.M. Palmer, and S. Moncada Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets Br J Pharmacol 92 1 1987 181 187
176. P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, and I. Mayers Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide Cancer Res 61 1 2001 376 382
177. D.G. Alleva, C.J. Burger, and K.D. Elgert Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2 J Immunol 153 4 1994 1674 1686
178. T.E. Gardner, H. Naama, and J.M. Daly Peritoneal and splenic macrophage functions in the tumor-bearing host J Surg Res 59 2 1995 305 310
179. M.R. Dinapoli, C.L. Calderon, and D.M. Lopez The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene J Exp Med 183 4 1996 1323 1329
180. J.E. Albina, B.A. Martin, W.L. Henry Jr., C.A. Louis, and J.S. Reichner B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity J Immunol 157 1 1996 279 283
181. A.J. Mackenzie-Graham, B. Mitrovic, A. Smoll, and J.E. Merrill Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines Dev Neurosci 16 3/4 1994 162 171
182. K. Xie, and S. Huang Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency Free Radic Biol Med 34 8 2003 969 986
183. S.H. Juang, K. Xie, L. Xu, Q. Shi, Y. Wang, and J. Yoneda Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene Hum Gene Ther 9 6 1998 845 854
184. S.H. Juang, K. Xie, L. Xu, Y. Wang, J. Yoneda, and I.J. Fidler Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma Cancer Biother Radiopharm 12 3 1997 167 175
185. K. Xie, S. Huang, Z. Dong, S.H. Juang, M. Gutman, and Q.W. Xie Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells J Exp Med 181 4 1995 1333 1343
186. A.E. Chang, J.D. Geiger, V.K. Sondak, and S. Shu Adoptive cellular therapy of malignancy Arch Surg 128 11 1993 1281 1290
187. J. Vuky, and R. Motzer Cytokine therapy in renal cell cancer Urol Oncol 5 2000 249 257
188. B. Wang, Q. Xiong, Q. Shi, X. Le, J.L. Abbruzzese, and K. Xie Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma Cancer Res 61 1 2001 71 75
189. G.H. Windbichler, H. Hausmaninger, W. Stummvoll, A.H. Graf, C. Kainz, and J. Lahodny Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial Br J Cancer 82 6 2000 1138 1144